These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 11794193

  • 1. Treatment of acute hepatitis C with interferon alfa-2b.
    Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, Pastore G, Dietrich M, Trautwein C, Manns MP, German Acute Hepatitis C Therapy Group.
    N Engl J Med; 2001 Nov 15; 345(20):1452-7. PubMed ID: 11794193
    [Abstract] [Full Text] [Related]

  • 2. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
    McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK.
    N Engl J Med; 1998 Nov 19; 339(21):1485-92. PubMed ID: 9819446
    [Abstract] [Full Text] [Related]

  • 3. Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.
    Kamal SM, Fouly AE, Kamel RR, Hockenjos B, Al Tawil A, Khalifa KE, He Q, Koziel MJ, El Naggar KM, Rasenack J, Afdhal NH.
    Gastroenterology; 2006 Mar 19; 130(3):632-8. PubMed ID: 16530503
    [Abstract] [Full Text] [Related]

  • 4. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J.
    N Engl J Med; 2002 Sep 26; 347(13):975-82. PubMed ID: 12324553
    [Abstract] [Full Text] [Related]

  • 5. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.
    Schvarcz R, Ando Y, Sönnerborg A, Weiland O.
    J Hepatol; 1995 Sep 26; 23 Suppl 2():17-21. PubMed ID: 8720289
    [Abstract] [Full Text] [Related]

  • 6. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
    Gallegos-Orozco JF, Fuentes AP, Olivera-Martinez MA, Gutiérrez-Reyes G, Cortina D, Oregel JA, Pérez-Pruna C, Sixtos MS, Cruz-Castellanos S, Soto-Ramírez LE, Rodríguez-Díaz R, Fuentes-Romero L, Gutiérrez-Ruiz MC, Kershenobich D.
    Rev Invest Clin; 2003 Sep 26; 55(2):138-42. PubMed ID: 12827916
    [Abstract] [Full Text] [Related]

  • 7. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
    Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, Shiffman ML, Zeuzem S, Craxi A, Ling MH, Albrecht J.
    N Engl J Med; 1998 Nov 19; 339(21):1493-9. PubMed ID: 9819447
    [Abstract] [Full Text] [Related]

  • 8. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C.
    Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Reed A, Hemming A, Howard R, Van Der Werf W, Lauwers G, Liu C, Crawford JM, Davis GL, Nelson DR.
    Liver Transpl; 2002 Nov 19; 8(11):1000-6. PubMed ID: 12424712
    [Abstract] [Full Text] [Related]

  • 9. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
    Keeffe EB, Hollinger FB.
    Hepatology; 1997 Sep 19; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
    [Abstract] [Full Text] [Related]

  • 10. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM, Perez RM, Narciso JL, Ferreira AP, Lemos LB, Medina-Pestana JO, Silva AE, Ferraz ML.
    Eur J Gastroenterol Hepatol; 2007 Feb 19; 19(2):119-23. PubMed ID: 17272996
    [Abstract] [Full Text] [Related]

  • 11. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC, Bacon BR, Goldin RD.
    Hepatology; 1998 Apr 19; 27(4):1121-7. PubMed ID: 9537453
    [Abstract] [Full Text] [Related]

  • 12. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis.
    Heathcote EJ, Shiffman ML, Cooksley WG, Dusheiko GM, Lee SS, Balart L, Reindollar R, Reddy RK, Wright TL, Lin A, Hoffman J, De Pamphilis J.
    N Engl J Med; 2000 Dec 07; 343(23):1673-80. PubMed ID: 11106716
    [Abstract] [Full Text] [Related]

  • 13. Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin.
    Buti M, Sanchez-Avila F, Lurie Y, Stalgis C, Valdés A, Martell M, Esteban R.
    Hepatology; 2002 Apr 07; 35(4):930-6. PubMed ID: 11915041
    [Abstract] [Full Text] [Related]

  • 14. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
    Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-García J, Lazzarin A, Carosi G, Sasadeusz J, Katlama C, Montaner J, Sette H, Passe S, De Pamphilis J, Duff F, Schrenk UM, Dieterich DT, APRICOT Study Group.
    N Engl J Med; 2004 Jul 29; 351(5):438-50. PubMed ID: 15282351
    [Abstract] [Full Text] [Related]

  • 15. Treatment of genotype 1b HCV-related chronic hepatitis: efficacy and toxicity of three different interferon alfa-2b/ribavirin combined regimens in naive patients.
    Scotto G, Fazio V, Palumbo E, Cibelli DC, Saracino A, Angarano G.
    New Microbiol; 2005 Jan 29; 28(1):23-9. PubMed ID: 15782623
    [Abstract] [Full Text] [Related]

  • 16. Peginterferon alfa-2a in patients with chronic hepatitis C.
    Zeuzem S, Feinman SV, Rasenack J, Heathcote EJ, Lai MY, Gane E, O'Grady J, Reichen J, Diago M, Lin A, Hoffman J, Brunda MJ.
    N Engl J Med; 2000 Dec 07; 343(23):1666-72. PubMed ID: 11106715
    [Abstract] [Full Text] [Related]

  • 17. Peginterferon alfa-2b treatment for patients affected by acute hepatitis C: presentation of six case reports.
    Scotto G, Palumbo E, Fazio V, Cibelli DC, Saracino A, Angarano G.
    Infection; 2005 Feb 07; 33(1):30-2. PubMed ID: 15750757
    [Abstract] [Full Text] [Related]

  • 18. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J, Jäckel E, Cornberg M, Hinrichsen H, Dietrich M, Kroeger J, Fritsch WP, Kubitschke A, Aslan N, Tillmann HL, Manns MP, Wedemeyer H.
    Hepatology; 2004 Jul 07; 40(1):98-107. PubMed ID: 15239091
    [Abstract] [Full Text] [Related]

  • 19. A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.
    Crippin JS, McCashland T, Terrault N, Sheiner P, Charlton MR.
    Liver Transpl; 2002 Apr 07; 8(4):350-5. PubMed ID: 11965579
    [Abstract] [Full Text] [Related]

  • 20. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
    Carrat F, Bani-Sadr F, Pol S, Rosenthal E, Lunel-Fabiani F, Benzekri A, Morand P, Goujard C, Pialoux G, Piroth L, Salmon-Céron D, Degott C, Cacoub P, Perronne C, ANRS HCO2 RIBAVIC Study Team.
    JAMA; 2004 Dec 15; 292(23):2839-48. PubMed ID: 15598915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.